title: Down-regulation of hypoxia-inducible factor-2 in PC12 cells by nerve growth factor stimulation.
abstract: Cellular responses to low oxygen tension are mediated, at least in part, by the activation of the hypoxia-inducible factors (HIFs). In the presence of oxygen, specific HIF residues become hydroxylated by the action of a recently described group of dioxygenases. These post-translational modifications target HIF for proteosomal degradation and prevent its transcriptional activity. Despite these detailed studies, little is known about the regulation of HIF by stimuli other than hypoxia. Here we report that, in rat pheochromocytoma PC12 cells, nerve growth factor (NGF) stimulation results in a decrease of both basal and hypoxia-induced levels of HIF-2 alpha protein. NGF treatment did not increase HIF-hydroxylase gene expression or activity, and the reduction of the HIF-2 alpha protein level upon stimulation was observed even in the presence of HIF-hydroxylase inhibitors such as deferoxamine or dimethyloxoglutarate. Thus, in contrast to the response to hypoxia, the effect of NGF on HIF-2 alpha protein levels is not mediated by the HIF hydroxilases. Quantitative real time (RT)-PCR showed that NGF stimulation results in a decrease of the HIF-2 alpha mRNA level similar to that found at the protein level. Interestingly, NGF effect was specific for HIF-2 alpha mRNA because it did not affect HIF-1 alpha mRNA levels. NGF treatment reduced HIF-2 alpha mRNA levels even in the presence of actinomycin D, suggesting an effect on mRNA stability. Finally, the effect of NGF on HIF2 alpha correlates with reduction of both basal and hypoxia-induced vascular endothelial growth factor mRNA levels. Reporter assays suggest that the reduced expression of hypoxia-inducible genes upon NGF treatment is related, at least in part, to the reduction of HIF-2 alpha protein. Hence, in PC12 cells the level of HIF-2 alpha protein and its effect on gene expression can be down-regulated by stimuli other than oxygen.
authors.affiliation: Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Diego de León 62, 28006 Madrid, Spain.
authors.forename: Salvador
authors.initials: S
authors.lastname: Naranjo-Suárez
authors.forename: María Carmen
authors.initials: MC
authors.lastname: Castellanos
authors.forename: Miguel
authors.initials: M
authors.lastname: Alvarez-Tejado
authors.forename: Alicia
authors.initials: A
authors.lastname: Vara
authors.forename: Manuel O
authors.initials: MO
authors.lastname: Landázuri
authors.forename: Luis
authors.initials: L
authors.lastname: del Peso
mesh_terms: D000818:Animals; D001483:Base Sequence; D051792:Basic Helix-Loop-Helix Proteins; D015342:DNA Probes; D015536:Down-Regulation / Q000187:drug effects*; D020932:Nerve Growth Factor / Q000494:pharmacology*; D016716:PC12 Cells; D011393:Procollagen-Proline Dioxygenase / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D015534:Trans-Activators / Q000235:genetics / Q000502:physiology*; D000099162:Endothelial PAS Domain-Containing Protein 1
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D015342:DNA Probes; D020932:Nerve Growth Factor; D011393:Procollagen-Proline Dioxygenase; D012333:RNA, Messenger; D015534:Trans-Activators; D000099162:Endothelial PAS Domain-Containing Protein 1